Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00541_DB01211_nanopub.RAKuC0Nh81tB5cd6FuoyLFEysUiZ5IOnmMMHXZ1JEuuT0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00541_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB01211 label "DDI between Vincristine and Clarithromycin - Clarithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Clarithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB01211]" assertion.
- drugbank_resource:DB00541_DB01211 identifier "drugbank_resource:DB00541_DB01211" assertion.
- drugbank_resource:DB00541_DB01211 title "DDI between Vincristine and Clarithromycin - Clarithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Clarithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB01211 assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB01211 assertion.